Alcon AG (ALC)
Alcon - Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference
Alcon - Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference
Profound Medical Corp. Announces Closing of Private Placement
Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
KORU Medical Systems Announces 510(k) Submission for Clearance of theFreedomEDGE® System with a Commercialized Oncology Biologic
Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
Treace to Present at 44th Annual J.P. Morgan Healthcare Conference
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Ultragenyx Completes Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference